Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells

References

• Warburg O. On the origin of cancer cells. Science 1956; 123:309 - 314
   PubMed Web of Science ®Google Scholar
• Klimberg VS, McClellan JL, Organ CH Jr. Honorary Lectureship. Glutamine, cancer and its therapy. Am J Surg 1996; 172:418 - 424
   PubMed Web of Science ®Google Scholar
• Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, et al. The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009; 8:3984 - 4001
   PubMed Web of Science ®Google Scholar
• Medina MA. Glutamine and cancer. J Nutr 2001; 131:2539 - 2542
   PubMed Web of Science ®Google Scholar
• Souba WW. Glutamine and cancer. Ann Surg 1993; 218:715 - 728
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Sloviter HA. Glycolysis and pasteur effect in rat reticulocytes. J Biol Chem 1973; 248:3035 - 3040
   PubMed Web of Science ®Google Scholar
• Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 2008; 105:18782 - 18787
   PubMed Web of Science ®Google Scholar
• Medina MA, Nunez de Castro I. Glutaminolysis and glycolysis interactions in proliferant cells. Int J Biochem 1990; 22:681 - 683
   PubMedGoogle Scholar
• Segura JA, Medina MA, Alonso FJ, Sanchez-Jimenez F, Nunez de Castro I. Glycolysis and glutaminolysis in perifused Ehrlich ascites tumour cells. Cell Biochem Funct 1989; 7:7 - 10
   PubMed Web of Science ®Google Scholar
• Aledo JC. Glutamine breakdown in rapidly dividing cells: waste or investment?. Bioessays 2004; 26:778 - 785
   PubMed Web of Science ®Google Scholar
• Reitzer LJ, Wice BM, Kennell D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem 1979; 254:2669 - 2676
   PubMed Web of Science ®Google Scholar
• Hitosugi T, Kang S, Vander Heiden MG, Chung TW, Elf S, Lythgoe K, et al. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2009; 2:73
   Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 2009; 324:1029 - 1033
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 2007; 104:19345 - 19350
   PubMed Web of Science ®Google Scholar
• Blaker GJ, Birch JR, Pirt SJ. The glucose, insulin and glutamine requirements of suspension cultures of HeLa cells in a defined culture medium. J Cell Sci 1971; 9:529 - 537
   PubMed Web of Science ®Google Scholar
• King MP, Attardi G. Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation. Science 1989; 246:500 - 503
   PubMed Web of Science ®Google Scholar
• Procaccio V, Mousson B, Beugnot R, Duborjal H, Feillet F, Putet G, et al. Nuclear DNA origin of mitochondrial complex I deficiency in fatal infantile lactic acidosis evidenced by transnuclear complementation of cultured fibroblasts. J Clin Invest 1999; 104:83 - 92
   PubMed Web of Science ®Google Scholar
• Malaisse WJ, Ladriere L, Jijakli H, Laatikainen R, Niemitz M, Verbruggen I, et al. Metabolism of the dimethyl ester of [2,3-(13)C]succinic acid in rat hepatocytes. Mol Cell Biochem 1998; 189:137 - 144
   PubMed Web of Science ®Google Scholar
• Koivunen P, Hirsila M, Gunzler V, Kivirikko KI, Myllyharju J. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem 2004; 279:9899 - 9904
   PubMed Web of Science ®Google Scholar
• Zlotnik A, Gruenbaum SE, Artru AA, Rozet I, Dubilet M, Tkachov S, et al. The neuroprotective effects of oxaloacetate in closed head injury in rats is mediated by its blood glutamate scavenging activity: evidence from the use of maleate. J Neurosurg Anesthesiol 2009; 21:235 - 241
   PubMed Web of Science ®Google Scholar
• Soderberg KL, Ditta GS, Scheffler IE. Mammalian cells with defective mitochondrial functions: A Chinese hamster mutant cell line lacking succinate dehydrogenase activity. Cell 1977; 10:697 - 702
   PubMed Web of Science ®Google Scholar
• Dang CV. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res 2010; 70:859 - 862
   PubMed Web of Science ®Google Scholar
• Silverstein E, Sulebele G. Equilibrium kinetic study of the catalytic mechanism of oxidative deamination of alanine by bovine liver glutamate dehydrogenase. Biochemistry 1974; 13:1815 - 1818
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16:675 - 686
   PubMed Web of Science ®Google Scholar
• Hertz L, Dringen R, Schousboe A, Robinson SR. Astrocytes: glutamate producers for neurons. J Neurosci Res 1999; 57:417 - 428
   PubMed Web of Science ®Google Scholar
• Safer B, Williamson JR. Mitochondrial-cytosolic interactions in perfused rat heart. Role of coupled transamination in repletion of citric acid cycle intermediates. J Biol Chem 1973; 248:2570 - 2579
   PubMed Web of Science ®Google Scholar
• Yang R-Z, Park S, Reagan WJ, Goldstein R, Zhong S, Lawton M, et al. Alanine aminotransferase isoenzymes: molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity. Hepatology 2009; 49:598 - 607
   PubMed Web of Science ®Google Scholar
• Yang RZ, Blaileanu G, Hansen BC, Shuldiner AR, Gong DW. cDNA cloning, genomic structure, chromosomal mapping and functional expression of a novel human alanine aminotransferase. Genomics 2002; 79:445 - 450
   PubMed Web of Science ®Google Scholar
• Bunpo P, Dudley A, Cundiff JK, Cavener DR, Wek RC, Anthony TG. GCN2 protein kinase is required to activate amino acid deprivation responses in mice treated with the anti-cancer agent L-asparaginase. J Biol Chem 2009; 284:32742 - 32749
   PubMed Web of Science ®Google Scholar
• Zhang P, McGrath BC, Reinert J, Olsen DS, Lei L, Gill S, et al. The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice. Mol Cell Biol 2002; 22:6681 - 6688
   PubMed Web of Science ®Google Scholar
• Kaadige MR, Looper RE, Kamalanaadhan S, Ayer DE. Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity. Proc Natl Acad Sci USA 2009; 106:14878 - 14883
   PubMed Web of Science ®Google Scholar
• Dang CV. PKM2 tyrosine phosphorylation and glutamine metabolism signal a different view of the Warburg effect. Sci Signal 2009; 2:75
   Web of Science ®Google Scholar
• Yuneva M. Finding an “Achilles' heel” of cancer: The role of glucose and glutamine metabolism in the survival of transformed cells. Cell Cycle 2008; 7:2083 - 2089
   PubMed Web of Science ®Google Scholar
• Dang CV. The interplay between MYC and HIF in the Warburg effect. Ernst Schering Found Symp Proc 2007; 35 - 53
   PubMedGoogle Scholar
• Yang H, Roth CM, Ierapetritou MG. A rational design approach for amino acid supplementation in hepatocyte culture. Biotechnol Bioeng 2009; 103:1176 - 1191
   PubMed Web of Science ®Google Scholar
• Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3:187 - 197
   PubMed Web of Science ®Google Scholar
• Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 2008; 8:705 - 713
   PubMed Web of Science ®Google Scholar
• Chen Y, Cairns R, Papandreou I, Koong A, Denko NC. Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect. PLoS One 2009; 4:e7033
   PubMed Web of Science ®Google Scholar
• Pollard PJ, El-Bahrawy M, Poulsom R, Elia G, Killick P, Kelly G, et al. Expression of HIF-1alpha, HIF-2alpha (EPAS1) and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations. J Clin Endocrinol Metab 2006; 91:4593 - 4598
   PubMed Web of Science ®Google Scholar
• Pollard PJ, Briere JJ, Alam NA, Barwell J, Barclay E, Wortham NC, et al. Accumulation of Krebs cycle intermediates and overexpression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 2005; 14:2231 - 2239
   PubMed Web of Science ®Google Scholar
• Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005; 7:77 - 85
   PubMed Web of Science ®Google Scholar
• Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability. Cancer Cell 2005; 8:143 - 153
   PubMed Web of Science ®Google Scholar
• Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458:762 - 765
   PubMed Web of Science ®Google Scholar
• Haussinger D, Gerok W. Hepatocyte heterogeneity in glutamate uptake by isolated perfused rat liver. Eur J Biochem 1983; 136:421 - 425
   PubMedGoogle Scholar
• Lo M, Wang YZ, Gout PW. The x(c)-cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol 2008; 215:593 - 602
   PubMed Web of Science ®Google Scholar
• Dang CV. MYC, microRNAs and glutamine addiction in cancers. Cell Cycle 2009; 8:3243 - 3245
   PubMed Web of Science ®Google Scholar
• Sheng YB, Badger TM, Asplund JM, Wixom RL. Incorporation of 15NH4Cl into histidine in adult man. J Nutr 1977; 107:621 - 630
   PubMed Web of Science ®Google Scholar
• Doolittle RF. Protein sequence comparisons: searching databases and aligning sequences. Curr Opin Biotechnol 1994; 5:24 - 28
   PubMedGoogle Scholar
• Liang D, Kong X, Sang N. Effects of histone deacetylase inhibitors on HIF-1. Cell Cycle 2006; 5:2430 - 2435
   PubMed Web of Science ®Google Scholar
• Semenza GL. HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr 2007; 39:231 - 234
   PubMed Web of Science ®Google Scholar
• Fath DM, Kong X, Liang D, Lin Z, Chou A, Jiang Y, et al. Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIFalpha. J Biol Chem 2006; 281:13612 - 13619
   PubMed Web of Science ®Google Scholar
• Stiehl DP, Fath DM, Liang D, Jiang Y, Sang N. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. Cancer Res 2007; 67:2256 - 2264
   PubMed Web of Science ®Google Scholar